Aditum Bio: A San Francisco-based pharmaceutical investment fund, advancing patient access to vital medicines.
Location
Oakland, CA, US
Founded
2019
Aditum Bio is a San Francisco-based pharmaceutical investment fund focused on acquiring and developing pharmaceutical assets. The firm specializes in early-stage investments, particularly Series A rounds, with a mission to advance patient access to vital medicines that might otherwise remain undeveloped.
Aditum Bio's portfolio includes Via Nova Therapeutics, which has raised $20 million. The firm's approach combines biotech venture capital with a patient-centric focus, aiming to translate scientific advancements into tangible benefits for patients. Aditum Bio's unique value proposition lies in its commitment to taking biotech venture capital in new directions to address unmet medical needs.
Aditum Bio - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series A1 (50.0%)
Series B1 (50.0%)
Stage Mix
Series A 50%Series B 50%
Concentration shown as share of disclosed investments by stage.